Masimo (Nasdaq: MASI) + today promised to accept one of the board members proposed by Politan Capital Management while taking more shots at the activist investor’s leader.
The device developer said it would appoint former Johnson & Johnson MedTech executive Michelle Brennan to the board if shareholders voted to expand it from five members to seven.
Politan nominated Brennan along with Politan Managing Partner and Chief Investment Officer Quentin Koffey for two board seats up for election at the annual shareholder meeting this month.
Masimo asked shareholders to vote for their director nominees — incumbents H Michael Cohen and Julie Shimer — and to support a non-binding, advisory vote on the board’s expansion.
Shimer — chair of the Masimo Board Nominating Committee — accused Koffey of having “a history of misstatement and distortion and no relevant experience” in a news release.…